IMHO, the upcoming CR is a no brainer. I would think NUH wants to complete it on this side of Xmas.
It is also a no brainer that for this particular stock, market will not get excited again until market sees real Revenue uplift.
So my strategy is to not look at the share price until end of Apr22. Let the CR to complete, let the Dec21 and Mar22 quarterlies to come in (I suspect the level of Revenue uplift that can excite market can only be seen in Mar22 quarter at the earliest).
I think whoever decides to stick around for a bit longer must look through at least the next 4-6 months. Otherwise, you might want to consider taking the hit now and move on.
- Forums
- ASX - By Stock
- NUH
- Ann: Nuheara Secures Global Supply Agreement With Sonova
Ann: Nuheara Secures Global Supply Agreement With Sonova, page-70
Featured News
Add NUH (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.91M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NUH (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online